Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1055)
  3. Book Section (64)
  4. Review (64)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2694)
  2. Department of Medicine (2694)
  3. Hematologic Malignancies, Division of (2694)
  4. Population Sciences Research Program (742)
  5. Survivorship Research (654)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (664)
  3. Maria Palomba (443)
  4. Ariela Noy (369)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (41)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (875)
  2. Journal of Clinical Oncology (277)
  3. Hematological Oncology (110)
  4. British Journal of Haematology (81)
  5. Leukemia and Lymphoma (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (940)
  2. American Society of Clinical Oncology (293)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2694)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Superior outcomes associated with earlier use: Experience with tositumomab and iodine I 131 tositumomab in 1,177 patients (pts) with low-grade, follicular, and transformed non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Gregory, S. A.; Leonard, J. P.; Vose, J. M.; Zelenetz, A. D.; Horning, S. J.; Knox, S. J.; Lister, T. A.; Radford, J. A.; Press, O. W.; Kaminski, M. S.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The utility of gemcitabine and vinorelbine in patients with blastic NK lymphoma (CD4(+)/CD56(+) hematodermic neoplasm)
    Meeting Abstract

    Ellis, L. R.; Horwitz, S. M.
    Blood (2005)

    Fulltext@MSK | Save
  • Phase I/II study of the anti-CD30 antibody MDX-060 in patients with refractory/relapsed CD30 positive lymphoma
    Meeting Abstract

    Borchmann, P.; Ansell, S.; Byrd, J.; Horwitz, S.; Strair, R.; Khan, K.; Fischkoff, S.; Yellin, M.; Engert, A.
    Annals of Oncology (2005)

    Fulltext@MSK | Save
  • Radioimmunotherapy -- Who, what, and when?
    Journal Article

    Hamlin, P. A.
    American Journal of Oncology Review (2005)

    Fulltext@MSK | Save
  • Occult leptomeningeal NHL: Go with the flow?
    Journal Article

    Noy, A.
    Blood (2005)

    Fulltext@MSK | Save
  • Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas
    Journal Article

    Fisher, R. I.; Kaminski, M. S.; Wahl, R. L.; Knox, S. J.; Zelenetz, A. D.; Vose, J. M.; Leonard, J. P.; Kroll, S.; Goldsmith, S. J.; Coleman, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I(131) tositumomab
    Journal Article

    Bennett, J. M.; Kaminski, M. S.; Leonard, J. P.; Vose, J. M.; Zelenetz, A. D.; Knox, S. J.; Horning, S.; Press, O. W.; Radford, J. A.; Kroll, S. M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Proteasome inhibitors in non-Hodgkin's lymphoma
    Journal Article

    Zelenetz, A.
    Journal of the National Comprehensive Cancer Network (2005)

    Fulltext@MSK | Save
  • HIV-associated lymphoma: Promising new results, but with toxicity
    Journal Article

    Straus, D. J.
    Blood (2005)

    Fulltext@MSK | Save
  • Comparative studies on erythropoietic agents
    Journal Article

    Straus, D.
    Journal of the National Comprehensive Cancer Network (2005)

    Fulltext@MSK | Save